Clotblog with Dr Samuel Goldhaber
View all posts »Self-monitoring INR and self-managing warfarin to reduce thromboembolic events
Jan 20, 2012 07:30 EST-
5Comments
-
Read later
A recent study published in the Lancet reports a 50% reduction in thromboembolic events among patients who self-monitor their INR and self-manage their warfarin dosing. Why aren't these practices more common?
See also:
Anticoagulation self-monitoring halves thromboembolic risk
Heneghan C, Ward A, Perera R, et al. Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet 2011; DOI:10.1016/S0140-6736(11)61294-4. Abstract.
Your comments
|
||||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
You must be a member (with full membership) to post a comment.
Already a member?
Enjoy all the benefits of theheart.org
With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.
Membership is free!












